Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 15, 2015
Pages: 28
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A5E773F6179EN
Leaflet:

Download PDF Leaflet

Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Actinium Pharmaceuticals, Inc. (ATNM) is a biopharmaceutical company. It specializes in development of drugs used to treat cancer. The company mainly focuses on the development of alpha particle linked antibodies to treat cancer. It develops cancer drugs by using its ATNM’s Alpha Particle Immunotherapy platform technology. Its pipeline products include Iomab-B which is used for hematopoietic stem cells transplantation, Bismab-A and Actimab-A are used in the treatment of acute myeloid leukemia and Pre-clinical development. ATNM's products are used for the treatment of metastatic colorectal and prostate cancers, prevention of blood supply to and growth of solid cancers, and treatment of leukemias, lymphomas and multiple myeloma. Its clients include National Cancer Institution, American Cancer Society, Leukemia & Lymphoma Society, Leukemia Research Foundation, and DKMS Americas. The company was formerly known as Cactus Ventures, Inc. ATNM is headquartered in New York, the US.

Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Actinium Pharma Raises US$5 Million In First Closing Of Venture Financing Round
Actinium Pharma Secures US$4.1 Million In Initial Closing Of Series E Financing Round
Partnerships
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine
Licensing Agreements
Actinium Pharma Enters Into Licensing Agreement With Fred Hutchinson Cancer Research Center For BC8
Equity Offering
Actinium Pharma Raises USD20 Million in Public Offering of Shares and warrants
Actinium Pharma Raises USD13.7 Million in Public Offering of Shares
Actinium Pharma Completes Second Tranche Of Private Placement Of Securities For US$3.3 Million
Actinium Pharma Completes Private Placement Of Shares For US$3.5 Million Upon Exercise Of Warrants
Actinium Pharma Plans IPO
Acquisition
Cactus Ventures Completes Acquisition Of Actinium Pharma In Reverse Takeover Transaction
Actinium Pharmaceuticals, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts, 2013
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Deals By Therapy Area, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Actinium Pharma Raises US$5 Million In First Closing Of Venture Financing Round
Actinium Pharma Secures US$4.1 Million In Initial Closing Of Series E Financing Round
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine
Actinium Pharma Enters Into Licensing Agreement With Fred Hutchinson Cancer Research Center For BC8
Actinium Pharma Raises USD20 Million in Public Offering of Shares and warrants
Actinium Pharma Raises USD13.7 Million in Public Offering of Shares
Actinium Pharma Completes Second Tranche Of Private Placement Of Securities For US$3.3 Million
Actinium Pharma Completes Private Placement Of Shares For US$3.5 Million Upon Exercise Of Warrants
Actinium Pharma Plans IPO
Cactus Ventures Completes Acquisition Of Actinium Pharma In Reverse Takeover Transaction
Actinium Pharmaceuticals, Inc., Key Competitors
Actinium Pharmaceuticals, Inc., Key Employees

LIST OF FIGURES
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Actinium Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Skip to top


Ask Your Question

Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: